Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Teladoc Health, Inc.
Report date April 26, 2017 · Filed April 28, 2017
Section 16 reporting ended · disclosed 2017-04-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,480,468 |
Reported balance
After 2017-04-26 transaction · row 1
1 source rowRow 1 · 2017-04-26 · Other · Disposed 2,000,000 · Balance 2,480,468 F1: Pro rata distribution from CHP III, L.P. to it partners. |
Filing footnotes · ownership attribution and instrument terms
F1: Pro rata distribution from CHP III, L.P. to it partners.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2017 Filed Apr 28, 2017 18:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | OtherCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-011157 · doc4.xml · nonDerivative · entry 1 CHP III LP · CIK 0001384619 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,480,468 F1 · kind: Pro rata distribution from CHP III, L.P. to it partners. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 15:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 324,000 | $16.23 | $5,258,520.00 |
DisclosureSEC source: 0000899243-16-035579 · doc4.xml · nonDerivative · entry 2 CHP III LP · CIK 0001384619 · 10% owner CHP III Management, L.L.C. · CIK 0001540704 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,480,468 F3 · price: Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.55, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. F2 · ownership.direct: CHP III Management, L.L.C.(the "GP") is the sole General Partner of CHP III, L.P. John K. Clarke, Brandon H. Hull and John J. Park (collectively, the "Managing Members") are Managing Members of the GP, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held of CHP III, L.P. (the "CHP III Shares"). Each of the GP and the Managing Members disclaims beneficial ownership of the CHP III Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 15:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 176,000 | $16.59 | $2,919,840.00 |
DisclosureSEC source: 0000899243-16-035579 · doc4.xml · nonDerivative · entry 1 CHP III LP · CIK 0001384619 · 10% owner CHP III Management, L.L.C. · CIK 0001540704 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,804,468 F1 · price: Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.85, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. F2 · ownership.direct: CHP III Management, L.L.C.(the "GP") is the sole General Partner of CHP III, L.P. John K. Clarke, Brandon H. Hull and John J. Park (collectively, the "Managing Members") are Managing Members of the GP, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held of CHP III, L.P. (the "CHP III Shares"). Each of the GP and the Managing Members disclaims beneficial ownership of the CHP III Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.